In a ranking of leading drug classes in the United States, based on professional health print journals ad spend between January and June 2020, antineoplastic agents ranked first, with 39.2 million U.S. dollars invested in professional print journals ad spend in the presented period.
Leading drug classes in the United States between January and June 2020, by professional health print journals ad spend (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Prescription drugs with largest print ad spend in the U.S. 2020
- Most advertised brands in medical journals in the U.S. 2018
- Magazine advertising expenditure in Germany 2008-2015
- Magazine advertising expenditure in Norway 2008-2015
- Most advertised categories in medical journals in the U.S. H1 2019
- Magazine advertising expenditure in Greece 2008-2015
- Magazine advertising revenue in Ireland 2018-2024
- Growth in magazine advertisement expenditure in MENA 2010-2024
- Magazine ad spend in India 2005-2016
Kantar Media. (July 13, 2020). Leading drug classes in the United States between January and June 2020, by professional health print journals ad spend (in million U.S. dollars) [Graph]. In Statista. Retrieved August 08, 2022, from https://www.statista.com/statistics/688425/drug-classes-print-ad-spend-usa/
Kantar Media. "Leading drug classes in the United States between January and June 2020, by professional health print journals ad spend (in million U.S. dollars)." Chart. July 13, 2020. Statista. Accessed August 08, 2022. https://www.statista.com/statistics/688425/drug-classes-print-ad-spend-usa/
Kantar Media. (2020). Leading drug classes in the United States between January and June 2020, by professional health print journals ad spend (in million U.S. dollars). Statista. Statista Inc.. Accessed: August 08, 2022. https://www.statista.com/statistics/688425/drug-classes-print-ad-spend-usa/
Kantar Media. "Leading Drug Classes in The United States between January and June 2020, by Professional Health Print Journals Ad Spend (in Million U.S. Dollars)." Statista, Statista Inc., 13 Jul 2020, https://www.statista.com/statistics/688425/drug-classes-print-ad-spend-usa/
Kantar Media, Leading drug classes in the United States between January and June 2020, by professional health print journals ad spend (in million U.S. dollars) Statista, https://www.statista.com/statistics/688425/drug-classes-print-ad-spend-usa/ (last visited August 08, 2022)